Would you consider just treating radiographic residual disease (as opposed to all original sites of disease involvement, per ILROG guidelines) in a patient with bulky early-stage Hodgkin's lymphoma of the mediastinum?   

For example, in a young patient where standard fields would be very large and you want to minimize toxicity



Answer from: Radiation Oncologist at Academic Institution
Comments
Medical Oncologist at Cancer Care Specialists/ Renown Oncology / UNR
Is XRT needed in bulky disease after PET negative ...
Sign in or Register to read more